| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.733 | 0.001 | 0.733 | Dihydrofolate reductase inhibitor | 0.355 0.002 DBMET03019 0.323 0.002 DBMET03020 0.56 0.001 DBMET03021 0.557 0.001 DBMET03026 0.324 0.002 DBMET03027 | ||
| 0.451 | 0.04 | 0.451 | Angiogenesis inhibitor | 0.413 0.049 DBMET03021 0.399 0.054 DBMET03026 0.248 0.125 DBMET03027 | ||
| 0.41 | 0.022 | 0.415 | Antimitotic | 0.175 0.099 DBMET03019 0.225 0.071 DBMET03020 0.415 0.021 DBMET03021 0.303 0.043 DBMET03026 0.368 0.029 DBMET03027 | DBMET03021 | |
| 0.354 | 0.023 | 0.422 | RNA-directed DNA polymerase inhibitor | 0.243 0.054 DBMET03019 0.2 0.1 DBMET03020 0.413 0.017 DBMET03021 0.422 0.016 DBMET03026 0.303 0.031 DBMET03027 | DBMET03026 | |
| 0.361 | 0.043 | 0.361 | Calcium channel activator | 0.326 0.068 DBMET03019 0.326 0.068 DBMET03020 0.322 0.071 DBMET03021 0.32 0.073 DBMET03026 | ||
| 0.31 | 0.002 | 0.31 | Purinergic P2X2 antagonist | 0.252 0.003 DBMET03019 0.238 0.003 DBMET03020 0.29 0.002 DBMET03021 0.296 0.002 DBMET03026 0.234 0.003 DBMET03027 | ||
| 0.372 | 0.098 | 0.376 | 5 Hydroxytryptamine release inhibitor | 0.342 0.122 DBMET03021 0.376 0.095 DBMET03026 0.333 0.13 DBMET03027 | DBMET03026 | |
| 0.275 | 0.01 | 0.335 | Interleukin 4 antagonist | 0.143 0.056 DBMET03019 0.118 0.089 DBMET03020 0.335 0.007 DBMET03021 0.308 0.008 DBMET03026 0.252 0.013 DBMET03027 | DBMET03021 | |
| 0.284 | 0.021 | 0.284 | I kappa B kinase epsilon inhibitor | 0.137 0.134 DBMET03019 0.278 0.024 DBMET03021 0.248 0.038 DBMET03026 0.254 0.035 DBMET03027 | ||
| 0.293 | 0.03 | 0.293 | TRKC antagonist | 0.139 0.111 DBMET03019 0.249 0.048 DBMET03021 0.242 0.051 DBMET03026 | ||
| 0.264 | 0.004 | 0.285 | Folate antagonist | 0.285 0.004 DBMET03019 0.221 0.007 DBMET03020 0.24 0.005 DBMET03021 0.248 0.005 DBMET03026 0.249 0.005 DBMET03027 | DBMET03019 | |
| 0.293 | 0.041 | 0.293 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.255 0.058 DBMET03021 0.23 0.071 DBMET03026 0.184 0.103 DBMET03027 | ||
| 0.27 | 0.023 | 0.31 | Tubulin antagonist | 0.171 0.048 DBMET03019 0.182 0.043 DBMET03020 0.31 0.018 DBMET03021 0.182 0.043 DBMET03026 0.295 0.02 DBMET03027 | DBMET03021 | |
| 0.344 | 0.102 | 0.455 | Histamine release inhibitor | 0.422 0.064 DBMET03021 0.339 0.105 DBMET03026 0.455 0.047 DBMET03027 | DBMET03027 | |
| 0.245 | 0.004 | 0.245 | Toll-Like receptor 3 antagonist | 0.206 0.005 DBMET03019 0.206 0.005 DBMET03020 0.183 0.008 DBMET03021 0.194 0.007 DBMET03026 0.12 0.03 DBMET03027 | ||
| 0.262 | 0.025 | 0.308 | Nitric-oxide synthase stimulant | 0.306 0.01 DBMET03019 0.303 0.011 DBMET03020 0.285 0.016 DBMET03021 0.308 0.01 DBMET03026 0.255 0.029 DBMET03027 | DBMET03026 | |
| 0.352 | 0.116 | 0.397 | Calcium channel L-type activator | 0.328 0.134 DBMET03019 0.328 0.134 DBMET03020 0.378 0.097 DBMET03021 0.397 0.083 DBMET03026 | DBMET03026 | |
| 0.249 | 0.03 | 0.249 | Protein-tyrosine kinase Lyn inhibitor | 0.111 0.093 DBMET03020 0.187 0.05 DBMET03021 0.115 0.089 DBMET03026 0.156 0.063 DBMET03027 | ||
| 0.25 | 0.031 | 0.25 | RET inhibitor | 0.184 0.047 DBMET03021 0.143 0.065 DBMET03026 0.103 0.094 DBMET03027 | ||
| 0.272 | 0.054 | 0.311 | DNA synthesis inhibitor | 0.278 0.052 DBMET03019 0.206 0.115 DBMET03020 0.279 0.052 DBMET03021 0.288 0.048 DBMET03026 0.311 0.04 DBMET03027 | DBMET03027 | |
| 0.246 | 0.038 | 0.246 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.243 0.038 DBMET03021 0.187 0.056 DBMET03026 0.179 0.06 DBMET03027 | ||
| 0.241 | 0.033 | 0.241 | Tumour necrosis factor antagonist | 0.2 0.053 DBMET03019 0.177 0.069 DBMET03020 0.215 0.045 DBMET03021 0.204 0.051 DBMET03026 0.182 0.066 DBMET03027 | ||
| 0.311 | 0.104 | 0.311 | Toll-Like receptor agonist | 0.289 0.118 DBMET03019 0.272 0.13 DBMET03021 0.304 0.109 DBMET03026 0.253 0.146 DBMET03027 | ||
| 0.301 | 0.094 | 0.421 | Transcription factor NF kappa B inhibitor | 0.421 0.059 DBMET03021 0.396 0.064 DBMET03026 0.334 0.082 DBMET03027 | DBMET03021 | |
| 0.295 | 0.092 | 0.348 | Vasodilator, coronary | 0.283 0.102 DBMET03019 0.28 0.105 DBMET03020 0.31 0.08 DBMET03021 0.248 0.136 DBMET03026 0.348 0.056 DBMET03027 | DBMET03027 | |
| 0.253 | 0.051 | 0.253 | Death-associated protein kinase 3 inhibitor | 0.245 0.054 DBMET03021 0.205 0.072 DBMET03026 0.149 0.124 DBMET03027 | ||
| 0.279 | 0.081 | 0.295 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.295 0.068 DBMET03021 0.244 0.112 DBMET03026 | DBMET03021 | |
| 0.217 | 0.021 | 0.217 | TRKB antagonist | 0.143 0.052 DBMET03021 0.15 0.047 DBMET03026 0.101 0.099 DBMET03027 | ||
| 0.224 | 0.031 | 0.224 | Lck kinase inhibitor | 0.189 0.045 DBMET03021 0.154 0.063 DBMET03026 0.125 0.081 DBMET03027 | ||
| 0.238 | 0.048 | 0.238 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.148 0.136 DBMET03019 0.165 0.113 DBMET03020 0.228 0.053 DBMET03021 0.19 0.083 DBMET03026 0.187 0.086 DBMET03027 | ||
| 0.256 | 0.069 | 0.284 | Dyrk kinase inhibitor | 0.284 0.058 DBMET03021 0.261 0.067 DBMET03026 0.171 0.118 DBMET03027 | DBMET03021 | |
| 0.216 | 0.031 | 0.282 | Heat shock protein 90 antagonist | 0.172 0.054 DBMET03019 0.282 0.013 DBMET03021 0.254 0.02 DBMET03026 | DBMET03021 | |
| 0.237 | 0.056 | 0.318 | DNA methylase inhibitor | 0.284 0.033 DBMET03021 0.318 0.023 DBMET03026 0.134 0.133 DBMET03027 | DBMET03026 | |
| 0.23 | 0.051 | 0.279 | Neurotrophic factor enhancer | 0.279 0.025 DBMET03021 0.262 0.032 DBMET03026 0.161 0.122 DBMET03027 | DBMET03021 | |
| 0.221 | 0.045 | 0.221 | Src kinase inhibitor | 0.202 0.053 DBMET03021 0.174 0.068 DBMET03026 0.158 0.078 DBMET03027 | ||
| 0.193 | 0.019 | 0.197 | Beta amyloid protein antagonist | 0.182 0.023 DBMET03021 0.195 0.018 DBMET03026 0.197 0.018 DBMET03027 | DBMET03027 | |
| 0.242 | 0.071 | 0.278 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.278 0.056 DBMET03021 0.256 0.065 DBMET03026 0.178 0.107 DBMET03027 | DBMET03021 | |
| 0.172 | 0.006 | 0.172 | Glutamate release inhibitor | 0.086 0.071 DBMET03019 0.083 0.081 DBMET03020 0.139 0.013 DBMET03021 0.157 0.008 DBMET03026 0.138 0.013 DBMET03027 | ||
| 0.19 | 0.027 | 0.19 | Ephrin antagonist | 0.138 0.041 DBMET03021 0.116 0.052 DBMET03026 0.092 0.07 DBMET03027 | ||
| 0.274 | 0.111 | 0.538 | Vasodilator, peripheral | 0.376 0.063 DBMET03019 0.538 0.022 DBMET03020 0.308 0.093 DBMET03021 0.224 0.15 DBMET03026 0.281 0.107 DBMET03027 | DBMET03020 | |
| 0.198 | 0.035 | 0.198 | MAP kinase kinase 5 inhibitor | 0.16 0.115 DBMET03019 0.179 0.064 DBMET03020 0.18 0.062 DBMET03021 0.186 0.052 DBMET03026 | ||
| 0.272 | 0.11 | 0.403 | Cholesterol antagonist | 0.262 0.117 DBMET03019 0.223 0.146 DBMET03020 0.32 0.079 DBMET03021 0.278 0.106 DBMET03026 0.403 0.049 DBMET03027 | DBMET03027 | |
| 0.162 | 0.003 | 0.162 | Dihydropteroate synthase inhibitor | 0.076 0.007 DBMET03019 0.058 0.012 DBMET03020 0.155 0.003 DBMET03021 0.147 0.004 DBMET03026 0.069 0.009 DBMET03027 | ||
| 0.215 | 0.062 | 0.304 | DNA methyltransferase I inhibitor | 0.276 0.036 DBMET03021 0.304 0.025 DBMET03026 | DBMET03026 | |
| 0.178 | 0.028 | 0.178 | Granulocyte macrophage colony stimulating factor antagonist | 0.1 0.071 DBMET03019 0.103 0.068 DBMET03021 0.104 0.067 DBMET03026 | ||
| 0.209 | 0.062 | 0.209 | Focal adhesion kinase 2 inhibitor | 0.157 0.119 DBMET03021 0.145 0.139 DBMET03026 | ||
| 0.189 | 0.046 | 0.189 | Protein kinase (CK1) gamma 1 inhibitor | 0.157 0.064 DBMET03021 0.157 0.063 DBMET03026 0.139 0.078 DBMET03027 | ||
| 0.159 | 0.024 | 0.182 | DNA repair enzyme inhibitor | 0.14 0.042 DBMET03019 0.131 0.054 DBMET03020 0.161 0.023 DBMET03021 0.182 0.013 DBMET03026 0.114 0.085 DBMET03027 | DBMET03026 | |
| 0.18 | 0.047 | 0.18 | Activin receptor-like kinase 2 inhibitor | 0.154 0.064 DBMET03021 0.119 0.098 DBMET03026 0.121 0.095 DBMET03027 | ||
| 0.202 | 0.075 | 0.202 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.202 0.075 DBMET03021 0.175 0.097 DBMET03026 0.139 0.131 DBMET03027 | ||
| 0.169 | 0.044 | 0.174 | MAP kinase 3 inhibitor | 0.16 0.054 DBMET03021 0.174 0.04 DBMET03026 | DBMET03026 | |
| 0.194 | 0.071 | 0.194 | Tyrosine kinase inhibitor | 0.124 0.105 DBMET03021 | ||
| 0.164 | 0.043 | 0.164 | Protein kinase (CK1) gamma 2 inhibitor | 0.138 0.054 DBMET03021 0.122 0.064 DBMET03026 0.105 0.078 DBMET03027 | ||
| 0.199 | 0.08 | 0.199 | Clk dual-specificity kinase inhibitor | 0.156 0.108 DBMET03021 0.16 0.105 DBMET03026 | ||
| 0.173 | 0.055 | 0.173 | Protein kinase (CK1) gamma inhibitor | 0.145 0.07 DBMET03021 0.13 0.081 DBMET03026 0.113 0.098 DBMET03027 | ||
| 0.313 | 0.195 | 0.313 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.213 | 0.095 | 0.287 | Aryl hydrocarbon receptor agonist | 0.214 0.095 DBMET03021 0.287 0.065 DBMET03026 | DBMET03026 | |
| 0.24 | 0.123 | 0.313 | Immunomodulator | 0.225 0.137 DBMET03021 0.24 0.123 DBMET03026 0.313 0.075 DBMET03027 | DBMET03027 | |
| 0.131 | 0.015 | 0.187 | Myeloperoxidase inhibitor | 0.158 0.01 DBMET03021 0.187 0.006 DBMET03026 | DBMET03026 | |
| 0.17 | 0.055 | 0.171 | CDC-like kinase 1 inhibitor | 0.148 0.072 DBMET03021 0.171 0.054 DBMET03026 0.128 0.087 DBMET03027 | DBMET03026 | |
| 0.27 | 0.159 | 0.375 | Antibacterial | 0.337 0.11 DBMET03019 0.351 0.101 DBMET03020 0.355 0.099 DBMET03021 0.375 0.088 DBMET03026 0.33 0.114 DBMET03027 | DBMET03026 | |
| 0.161 | 0.051 | 0.161 | Vascular endothelial growth factor antagonist | 0.1 0.081 DBMET03021 | ||
| 0.124 | 0.015 | 0.124 | mTOR complex 2 inhibitor | 0.12 0.017 DBMET03021 0.122 0.017 DBMET03026 0.11 0.024 DBMET03027 | ||
| 0.112 | 0.008 | 0.166 | Heat shock protein 90 beta antagonist | 0.166 0.004 DBMET03021 0.134 0.005 DBMET03026 | DBMET03021 | |
| 0.168 | 0.067 | 0.168 | Polo-like kinase-3 inhibitor | 0.148 0.087 DBMET03021 0.129 0.11 DBMET03026 0.137 0.1 DBMET03027 | ||
| 0.15 | 0.049 | 0.15 | Vascular endothelial growth factor 2 antagonist | 0.09 0.079 DBMET03021 | ||
| 0.118 | 0.018 | 0.118 | Fibroblast growth factor 2 antagonist | 0.085 0.031 DBMET03021 0.082 0.032 DBMET03026 0.106 0.022 DBMET03027 | ||
| 0.12 | 0.02 | 0.12 | Adenosine A2a receptor antagonist | 0.093 0.027 DBMET03021 0.101 0.025 DBMET03026 0.119 0.02 DBMET03027 | ||
| 0.135 | 0.037 | 0.135 | Fibroblast growth factor 1 antagonist | 0.099 0.058 DBMET03021 0.079 0.075 DBMET03026 0.094 0.062 DBMET03027 | ||
| 0.116 | 0.019 | 0.127 | Granulocyte macrophage colony stimulating factor agonist | 0.093 0.045 DBMET03019 0.093 0.045 DBMET03020 0.127 0.012 DBMET03021 0.119 0.016 DBMET03026 0.098 0.038 DBMET03027 | DBMET03021 | |
| 0.157 | 0.06 | 0.157 | Tyrosine-protein kinase receptor antagonist | 0.107 0.1 DBMET03021 0.119 0.088 DBMET03026 | ||
| 0.153 | 0.056 | 0.16 | MAP3K9 inhibitor | 0.144 0.069 DBMET03021 0.152 0.056 DBMET03026 0.16 0.046 DBMET03027 | DBMET03027 | |
| 0.118 | 0.022 | 0.125 | Adenosine A2 receptor antagonist | 0.084 0.033 DBMET03021 0.09 0.03 DBMET03026 0.125 0.021 DBMET03027 | DBMET03027 | |
| 0.119 | 0.024 | 0.119 | Interleukin 5 antagonist | 0.114 0.028 DBMET03021 0.115 0.028 DBMET03026 0.085 0.062 DBMET03027 | ||
| 0.246 | 0.151 | 0.249 | Toll-Like receptor 7 agonist | 0.243 0.153 DBMET03019 0.221 0.177 DBMET03021 0.249 0.149 DBMET03026 0.203 0.197 DBMET03027 | DBMET03026 | |
| 0.133 | 0.044 | 0.133 | Platelet activating factor beta antagonist | 0.086 0.074 DBMET03021 | ||
| 0.102 | 0.013 | 0.102 | ZAP-70 protein tyrosine kinase inhibitor | 0.071 0.046 DBMET03019 0.067 0.052 DBMET03020 0.094 0.018 DBMET03021 0.09 0.022 DBMET03026 0.087 0.026 DBMET03027 | ||
| 0.122 | 0.033 | 0.122 | Insulin growth factor antagonist | 0.115 0.037 DBMET03021 0.103 0.045 DBMET03026 0.087 0.058 DBMET03027 | ||
| 0.135 | 0.047 | 0.135 | Vascular endothelial growth factor 1 antagonist | 0.085 0.077 DBMET03021 | ||
| 0.108 | 0.02 | 0.147 | Beta tubulin antagonist | 0.053 0.044 DBMET03020 0.147 0.012 DBMET03021 0.095 0.024 DBMET03026 0.053 0.044 DBMET03027 | DBMET03021 | |
| 0.291 | 0.204 | 0.344 | Caspase 9 stimulant | 0.344 0.15 DBMET03021 0.267 0.233 DBMET03026 | DBMET03021 | |
| 0.137 | 0.052 | 0.137 | Platelet activating factor antagonist | |||
| 0.11 | 0.025 | 0.11 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.067 0.057 DBMET03026 | ||
| 0.114 | 0.03 | 0.114 | AXL receptor tyrosine kinase inhibitor | 0.083 0.057 DBMET03021 0.097 0.042 DBMET03026 | ||
| 0.16 | 0.077 | 0.218 | Heat shock protein 90 alpha antagonist | 0.133 0.106 DBMET03019 0.218 0.039 DBMET03021 0.191 0.055 DBMET03026 | DBMET03021 | |
| 0.144 | 0.062 | 0.158 | Heat shock protein 70 antagonist | 0.158 0.031 DBMET03021 0.14 0.074 DBMET03026 | DBMET03021 | |
| 0.123 | 0.044 | 0.123 | Acetylcholine release stimulant | 0.105 0.077 DBMET03020 | ||
| 0.153 | 0.076 | 0.153 | Cyclin-dependent kinase 8 inhibitor | 0.136 0.095 DBMET03021 0.137 0.093 DBMET03026 | ||
| 0.104 | 0.027 | 0.104 | Focal adhesion kinase 1 inhibitor | 0.085 0.044 DBMET03021 0.078 0.051 DBMET03026 0.068 0.066 DBMET03027 | ||
| 0.116 | 0.04 | 0.116 | Nitric-oxide synthase inhibitor | 0.103 0.054 DBMET03019 0.099 0.062 DBMET03021 0.104 0.054 DBMET03026 | ||
| 0.157 | 0.082 | 0.157 | Protein kinase (CK1) gamma 3 inhibitor | 0.149 0.09 DBMET03021 0.143 0.097 DBMET03026 | ||
| 0.113 | 0.039 | 0.113 | mTOR complex 1 inhibitor | 0.102 0.057 DBMET03021 0.106 0.051 DBMET03026 | ||
| 0.212 | 0.138 | 0.283 | Hypoxia-inducible factor 1 alpha inhibitor | 0.278 0.078 DBMET03021 0.283 0.074 DBMET03026 | DBMET03026 | |
| 0.108 | 0.036 | 0.108 | ALK inhibitor | 0.077 0.064 DBMET03021 0.082 0.057 DBMET03026 0.074 0.068 DBMET03027 | ||
| 0.14 | 0.07 | 0.161 | Cytokine production inhibitor | 0.115 0.094 DBMET03021 0.161 0.054 DBMET03027 | DBMET03027 | |
| 0.107 | 0.037 | 0.107 | Insulin like growth factor 1 antagonist | 0.093 0.047 DBMET03021 0.086 0.054 DBMET03026 | ||
| 0.147 | 0.078 | 0.15 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.15 0.073 DBMET03021 0.14 0.092 DBMET03026 | DBMET03021 | |
| 0.112 | 0.043 | 0.119 | Protein kinase C delta inhibitor | 0.103 0.049 DBMET03021 0.119 0.038 DBMET03026 | DBMET03026 | |
| 0.111 | 0.044 | 0.111 | Electrolyte absorption antagonist | 0.094 0.066 DBMET03021 0.107 0.049 DBMET03026 | ||
| 0.181 | 0.116 | 0.326 | Aldehyde oxidase inhibitor | 0.326 0.06 DBMET03021 0.217 0.096 DBMET03026 | DBMET03021 | |
| 0.14 | 0.076 | 0.14 | Growth factor antagonist | 0.109 0.104 DBMET03021 0.108 0.105 DBMET03026 | ||
| 0.092 | 0.028 | 0.092 | CDK1/cyclin B inhibitor | 0.076 0.036 DBMET03021 0.082 0.033 DBMET03026 | ||
| 0.128 | 0.065 | 0.128 | Epidermal growth factor receptor kinase inhibitor | 0.115 0.079 DBMET03021 0.108 0.087 DBMET03026 | ||
| 0.118 | 0.056 | 0.125 | Cyclin-dependent kinase 1 inhibitor | 0.109 0.06 DBMET03021 0.125 0.052 DBMET03026 0.09 0.074 DBMET03027 | DBMET03026 | |
| 0.108 | 0.048 | 0.108 | Phosphodiesterase 7B inhibitor | 0.083 0.081 DBMET03019 | ||
| 0.149 | 0.089 | 0.149 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.135 0.1 DBMET03021 | ||
| 0.082 | 0.024 | 0.082 | Phosphatidylinositol 3-kinase delta inhibitor | 0.061 0.037 DBMET03021 0.063 0.035 DBMET03026 | ||
| 0.141 | 0.083 | 0.23 | MAP kinase kinase 4 inhibitor | 0.144 0.075 DBMET03021 0.15 0.062 DBMET03026 0.23 0.007 DBMET03027 | DBMET03027 | |
| 0.073 | 0.017 | 0.073 | Histamine agonist | |||
| 0.104 | 0.049 | 0.104 | CDK/cyclin complex inhibitor | 0.088 0.061 DBMET03021 0.088 0.061 DBMET03026 | ||
| 0.076 | 0.021 | 0.14 | Alpha tubulin antagonist | 0.056 0.034 DBMET03019 0.057 0.033 DBMET03020 0.129 0.012 DBMET03021 0.075 0.021 DBMET03026 0.14 0.01 DBMET03027 | DBMET03027 | |
| 0.104 | 0.053 | 0.104 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.098 | 0.048 | 0.098 | Polo-like kinase-1 inhibitor | 0.082 0.079 DBMET03021 0.088 0.066 DBMET03026 0.097 0.05 DBMET03027 | ||
| 0.105 | 0.055 | 0.105 | Insulin receptor antagonist | 0.089 0.08 DBMET03026 | ||
| 0.075 | 0.026 | 0.075 | EphB4 antagonist | 0.063 0.035 DBMET03021 | ||
| 0.207 | 0.159 | 0.27 | Caspase 3 stimulant | 0.27 0.096 DBMET03021 0.22 0.143 DBMET03026 | DBMET03021 | |
| 0.121 | 0.074 | 0.124 | c-Src kinase inhibitor | 0.124 0.072 DBMET03021 0.105 0.086 DBMET03026 0.109 0.083 DBMET03027 | DBMET03021 | |
| 0.055 | 0.009 | 0.055 | Purinergic P2X3 antagonist | 0.042 0.015 DBMET03019 0.04 0.017 DBMET03021 0.045 0.013 DBMET03026 | ||
| 0.147 | 0.101 | 0.147 | LIM domain kinase 1 inhibitor | |||
| 0.129 | 0.084 | 0.157 | Protein kinase C nu inhibitor | 0.128 0.084 DBMET03021 0.157 0.066 DBMET03026 | DBMET03026 | |
| 0.102 | 0.057 | 0.102 | Platelet activating factor alpha antagonist | |||
| 0.088 | 0.044 | 0.088 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.087 0.045 DBMET03021 | ||
| 0.088 | 0.044 | 0.088 | Phosphodiesterase 3A inhibitor | 0.077 0.061 DBMET03021 0.073 0.067 DBMET03026 | ||
| 0.142 | 0.099 | 0.142 | CDC-like kinase 2 inhibitor | |||
| 0.086 | 0.043 | 0.09 | Interferon agonist | 0.081 0.051 DBMET03021 0.09 0.038 DBMET03026 0.084 0.046 DBMET03027 | DBMET03026 | |
| 0.073 | 0.03 | 0.077 | Interferon inducer | 0.069 0.036 DBMET03021 0.077 0.026 DBMET03026 0.071 0.034 DBMET03027 | DBMET03026 | |
| 0.08 | 0.038 | 0.139 | Phenylalanine 4-hydroxylase inhibitor | 0.139 0.014 DBMET03021 0.121 0.018 DBMET03026 0.106 0.023 DBMET03027 | DBMET03021 | |
| 0.082 | 0.04 | 0.093 | MAP kinase kinase 7 inhibitor | 0.088 0.028 DBMET03021 0.093 0.02 DBMET03026 0.074 0.067 DBMET03027 | DBMET03026 | |
| 0.107 | 0.066 | 0.119 | Protein kinase C gamma inhibitor | 0.119 0.053 DBMET03021 0.119 0.054 DBMET03026 | DBMET03026 | |
| 0.078 | 0.037 | 0.078 | CDC7 inhibitor | 0.061 0.055 DBMET03021 | ||
| 0.108 | 0.067 | 0.108 | Electron transport complex I inhibitor | 0.107 0.068 DBMET03021 | ||
| 0.064 | 0.024 | 0.071 | Antimetabolite | 0.041 0.039 DBMET03019 0.067 0.023 DBMET03021 0.071 0.021 DBMET03026 | DBMET03026 | |
| 0.089 | 0.048 | 0.091 | Inducible nitric-oxide synthase inhibitor | 0.091 0.046 DBMET03019 0.08 0.062 DBMET03021 0.082 0.058 DBMET03026 | DBMET03019 | |
| 0.113 | 0.073 | 0.113 | TRKA antagonist | |||
| 0.084 | 0.045 | 0.186 | Phosphodiesterase 4D inhibitor | 0.186 0.012 DBMET03019 0.125 0.026 DBMET03020 | DBMET03019 | |
| 0.043 | 0.004 | 0.043 | Toll-Like receptor 8 agonist | 0.019 0.018 DBMET03019 0.027 0.005 DBMET03021 0.032 0.004 DBMET03026 0.021 0.012 DBMET03027 | ||
| 0.066 | 0.03 | 0.066 | CDK4/cyclin D inhibitor | 0.063 0.034 DBMET03021 0.059 0.041 DBMET03026 | ||
| 0.056 | 0.02 | 0.056 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.134 | 0.099 | 0.134 | GABA C receptor rho-2 antagonist | 0.13 0.106 DBMET03026 | ||
| 0.219 | 0.185 | 0.226 | GABA C receptor rho-3 antagonist | 0.226 0.178 DBMET03026 | DBMET03026 | |
| 0.085 | 0.052 | 0.085 | TIE-2 antagonist | |||
| 0.093 | 0.06 | 0.114 | Protein kinase C zeta inhibitor | 0.111 0.039 DBMET03021 0.114 0.036 DBMET03026 | DBMET03026 | |
| 0.067 | 0.035 | 0.067 | Adenosine A1 receptor antagonist | 0.057 0.042 DBMET03021 0.06 0.039 DBMET03026 0.053 0.046 DBMET03027 | ||
| 0.085 | 0.054 | 0.085 | TIE antagonist | |||
| 0.097 | 0.066 | 0.097 | Cyclin-dependent kinase 9 inhibitor | 0.089 0.076 DBMET03021 | ||
| 0.066 | 0.037 | 0.066 | CDK2/cyclin E inhibitor | 0.055 0.048 DBMET03021 | ||
| 0.089 | 0.06 | 0.089 | Phosphodiesterase I inhibitor | 0.08 0.077 DBMET03026 | ||
| 0.097 | 0.068 | 0.299 | Check point kinase 2 inhibitor | 0.299 0.006 DBMET03027 | DBMET03027 | |
| 0.082 | 0.055 | 0.082 | Platelet growth factor antagonist | 0.072 0.066 DBMET03026 | ||
| 0.144 | 0.118 | 0.144 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.135 0.129 DBMET03021 | ||
| 0.043 | 0.017 | 0.068 | Phosphoglycerate kinase inhibitor | 0.054 0.013 DBMET03021 0.068 0.01 DBMET03026 0.05 0.014 DBMET03027 | DBMET03026 | |
| 0.084 | 0.059 | 0.085 | Factor XII inhibitor | 0.082 0.062 DBMET03019 0.085 0.057 DBMET03020 | DBMET03020 | |
| 0.125 | 0.101 | 0.125 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.123 0.103 DBMET03021 | ||
| 0.141 | 0.118 | 0.141 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.136 | 0.113 | 0.136 | CDC-like kinase 4 inhibitor | |||
| 0.09 | 0.069 | 0.234 | DNA directed RNA polymerase inhibitor | 0.1 0.056 DBMET03026 0.234 0.01 DBMET03027 | DBMET03027 | |
| 0.119 | 0.098 | 0.138 | Nav1.6 sodium channel blocker | 0.138 0.069 DBMET03027 | DBMET03027 | |
| 0.089 | 0.068 | 0.089 | CDK2/cyclin A inhibitor | |||
| 0.052 | 0.032 | 0.052 | Adenosine A2b receptor antagonist | |||
| 0.051 | 0.032 | 0.051 | Phosphatidylinositol 3-kinase beta inhibitor | 0.046 0.039 DBMET03026 | ||
| 0.144 | 0.126 | 0.152 | P-glycoprotein inhibitor | 0.152 0.114 DBMET03021 | DBMET03021 | |
| 0.25 | 0.233 | 0.25 | MAP kinase 1 inhibitor | |||
| 0.047 | 0.031 | 0.048 | Thymidylate synthase inhibitor | 0.045 0.034 DBMET03021 0.048 0.03 DBMET03026 | DBMET03026 | |
| 0.13 | 0.114 | 0.13 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.118 | 0.102 | 0.321 | Peroxidase inhibitor | 0.265 0.044 DBMET03021 0.321 0.033 DBMET03026 0.149 0.078 DBMET03027 | DBMET03026 | |
| 0.059 | 0.045 | 0.059 | Cyclin D1 inhibitor | |||
| 0.057 | 0.044 | 0.057 | Phosphatidylinositol kinase inhibitor | |||
| 0.114 | 0.101 | 0.114 | Vascular endothelial growth factor 3 antagonist | |||
| 0.101 | 0.089 | 0.101 | Cyclin-dependent kinase inhibitor | |||
| 0.02 | 0.007 | 0.029 | Prokineticin receptor 1 antagonist | 0.018 0.009 DBMET03019 0.029 0.003 DBMET03020 0.016 0.013 DBMET03026 0.019 0.009 DBMET03027 | DBMET03020 | |
| 0.07 | 0.058 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.13 | 0.118 | 0.144 | CF transmembrane conductance regulator agonist | 0.13 0.117 DBMET03021 0.144 0.087 DBMET03026 | DBMET03026 | |
| 0.067 | 0.055 | 0.067 | Secretase beta inhibitor | |||
| 0.055 | 0.044 | 0.056 | CDK4/cyclin D1 inhibitor | 0.056 0.042 DBMET03021 | DBMET03021 | |
| 0.043 | 0.032 | 0.047 | AICAR transformylase inhibitor | 0.042 0.034 DBMET03021 0.047 0.026 DBMET03026 0.044 0.031 DBMET03027 | DBMET03026 | |
| 0.055 | 0.045 | 0.055 | Protein kinase C theta inhibitor | |||
| 0.053 | 0.044 | 0.067 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.051 0.047 DBMET03021 0.057 0.038 DBMET03026 0.067 0.028 DBMET03027 | DBMET03027 | |
| 0.045 | 0.036 | 0.045 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.018 | 0.01 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.011 DBMET03019 0.016 0.014 DBMET03021 0.016 0.013 DBMET03026 0.016 0.013 DBMET03027 | ||
| 0.09 | 0.082 | 0.09 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.071 | 0.063 | 0.071 | Fibroblast growth factor 3 antagonist | |||
| 0.053 | 0.046 | 0.053 | Immunoglobulin Fc receptor antagonist | |||
| 0.152 | 0.145 | 0.242 | Antiamyloidogenic | 0.231 0.08 DBMET03021 0.242 0.075 DBMET03026 | DBMET03026 | |
| 0.092 | 0.085 | 0.092 | EphA2 antagonist | |||
| 0.064 | 0.058 | 0.064 | I kappa B kinase 1 inhibitor | |||
| 0.058 | 0.053 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.035 | 0.03 | 0.035 | Diamine oxidase inhibitor | |||
| 0.039 | 0.035 | 0.039 | Histamine H2 receptor agonist | |||
| 0.091 | 0.088 | 0.175 | Cystathionine beta-synthase inhibitor | 0.153 0.039 DBMET03021 0.175 0.031 DBMET03026 | DBMET03026 | |
| 0.013 | 0.01 | 0.015 | 5 Lipoxygenase activating protein inhibitor | 0.015 0.007 DBMET03027 | DBMET03027 | |
| 0.008 | 0.005 | 0.008 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.006 DBMET03021 0.007 0.005 DBMET03026 0.007 0.006 DBMET03027 | ||
| 0.067 | 0.065 | 0.067 | ErbB-2 antagonist | |||
| 0.011 | 0.01 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.009 DBMET03026 | ||
| 0.042 | 0.042 | 0.217 | Phosphodiesterase 4A inhibitor | 0.217 0.006 DBMET03019 0.128 0.012 DBMET03020 | DBMET03019 | |
| 0.06 | 0.061 | 0.07 | CDK1/cyclin B1 inhibitor | 0.07 0.048 DBMET03026 | DBMET03026 | |
| 0.058 | 0.06 | 0.067 | Cyclin B3 inhibitor | 0.067 0.048 DBMET03021 0.063 0.052 DBMET03026 | DBMET03021 | |
| 0.052 | 0.054 | 0.054 | Cyclin B1 inhibitor | 0.054 0.052 DBMET03021 | DBMET03021 | |
| 0.081 | 0.086 | 0.139 | MAP kinase kinase 1 inhibitor | 0.085 0.078 DBMET03026 0.139 0.021 DBMET03027 | DBMET03027 | |
| 0.067 | 0.077 | 0.119 | Carbonic anhydrase VI inhibitor | 0.099 0.04 DBMET03021 0.119 0.03 DBMET03026 | DBMET03026 | |
| 0.117 | 0.132 | 0.145 | Adenylate cyclase stimulant | 0.145 0.072 DBMET03021 0.122 0.119 DBMET03026 | DBMET03021 | |
| 0.07 | 0.095 | 0.122 | HIV-1 integrase (Overall Integration) inhibitor | 0.102 0.053 DBMET03021 0.122 0.038 DBMET03026 | DBMET03026 | |
| 0.048 | 0.074 | 0.079 | Transcription factor AP-1 inhibitor | 0.057 0.052 DBMET03021 0.079 0.022 DBMET03027 | DBMET03027 | |
| 0.087 | 0.115 | 0.131 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.114 0.088 DBMET03021 0.131 0.073 DBMET03026 | DBMET03026 | |
| 0.153 | 0.182 | 0.201 | Superoxide dismutase inhibitor | 0.201 0.116 DBMET03021 0.181 0.14 DBMET03026 | DBMET03021 | |
| 0.038 | 0.067 | 0.051 | Dopamine beta hydroxylase inhibitor | 0.045 0.042 DBMET03021 0.051 0.029 DBMET03026 | DBMET03026 | |
| 0.037 | 0.069 | 0.108 | Phosphodiesterase 4C inhibitor | 0.108 0.013 DBMET03019 0.073 0.025 DBMET03020 | DBMET03019 | |
| 0.082 | 0.121 | 0.176 | MAP kinase kinase inhibitor | 0.176 0.038 DBMET03027 | DBMET03027 | |
| 0.032 | 0.072 | 0.07 | Xanthine dehydrogenase inhibitor | 0.065 0.035 DBMET03021 0.07 0.031 DBMET03026 | DBMET03026 | |
| 0.031 | 0.072 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.044 0.023 DBMET03020 0.038 0.037 DBMET03026 | DBMET03020 | |
| 0.036 | 0.077 | 0.045 | Topoisomerase II beta inhibitor | 0.045 0.042 DBMET03021 | DBMET03021 | |
| 0.123 | 0.166 | 0.138 | Non-steroidal antiinflammatory agent | 0.138 0.133 DBMET03026 | DBMET03026 | |
| 0.075 | 0.121 | 0.09 | Carbonic anhydrase XV inhibitor | 0.09 0.084 DBMET03021 | DBMET03021 | |
| 0.044 | 0.094 | 0.069 | Histidine decarboxylase inhibitor | 0.069 0.052 DBMET03021 | DBMET03021 | |
| 0.14 | 0.191 | 0.188 | DNA damaging | 0.188 0.126 DBMET03019 0.162 0.156 DBMET03026 | DBMET03019 | |
| 0.136 | 0.189 | 0.167 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.129 DBMET03019 0.159 0.129 DBMET03020 0.16 0.125 DBMET03021 0.167 0.113 DBMET03026 | DBMET03026 | |
| 0.05 | 0.105 | 0.1 | Phosphodiesterase IV inhibitor | 0.1 0.045 DBMET03019 0.082 0.059 DBMET03020 | DBMET03019 | |
| 0.047 | 0.102 | 0.07 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.07 0.061 DBMET03021 0.069 0.063 DBMET03026 | DBMET03021 | |
| 0.131 | 0.191 | 0.152 | Cyclic AMP phosphodiesterase inhibitor | 0.152 0.148 DBMET03027 | DBMET03027 | |
| 0.059 | 0.12 | 0.071 | GABA B receptor agonist | 0.071 0.065 DBMET03021 | DBMET03021 | |
| 0.076 | 0.143 | 0.112 | DOPA decarboxylase inhibitor | 0.104 0.069 DBMET03021 0.112 0.056 DBMET03026 | DBMET03026 | |
| 0.05 | 0.117 | 0.071 | Protein kinase A inhibitor | 0.071 0.07 DBMET03026 | DBMET03026 | |
| 0.115 | 0.185 | 0.147 | ATPase inhibitor | 0.147 0.106 DBMET03026 | DBMET03026 | |
| 0.08 | 0.151 | 0.119 | Toll-Like receptor 2 antagonist | 0.119 0.078 DBMET03021 0.109 0.091 DBMET03026 | DBMET03021 | |
| 0.061 | 0.133 | 0.087 | Expectorant | 0.087 0.085 DBMET03021 | DBMET03021 | |
| 0.027 | 0.114 | 0.083 | HIV-1 integrase (Strand Transfer) inhibitor | 0.071 0.035 DBMET03021 0.083 0.029 DBMET03026 | DBMET03026 | |
| 0.112 | 0.205 | 0.299 | Free radical scavenger | 0.171 0.123 DBMET03019 0.157 0.137 DBMET03020 0.287 0.055 DBMET03021 0.299 0.052 DBMET03026 | DBMET03026 | |
| 0.114 | 0.211 | 0.213 | Tumour necrosis factor alpha release inhibitor | 0.213 0.098 DBMET03019 | DBMET03019 | |
| 0.094 | 0.206 | 0.126 | Melanin inhibitor | 0.126 0.122 DBMET03021 0.126 0.121 DBMET03026 | DBMET03026 | |
| 0.111 | 0.23 | 0.15 | Death-associated protein kinase 2 inhibitor | 0.15 0.105 DBMET03021 | DBMET03021 | |
| 0.055 | 0.185 | 0.149 | DNA polymerase I inhibitor | 0.111 0.076 DBMET03021 0.149 0.05 DBMET03026 | DBMET03026 | |
| 0.031 | 0.164 | 0.049 | Vanilloid 2 antagonist | 0.049 0.045 DBMET03021 | DBMET03021 | |
| 0.037 | 0.185 | 0.097 | Ornithine decarboxylase inhibitor | 0.097 0.047 DBMET03027 | DBMET03027 | |
| 0.065 | 0.223 | 0.191 | Amyloid beta aggregation inhibitor | 0.191 0.083 DBMET03021 0.183 0.087 DBMET03026 | DBMET03021 | |
| 0.023 | 0.184 | 0.073 | HIV-1 integrase (3'-Processing) inhibitor | 0.064 0.043 DBMET03021 0.073 0.037 DBMET03026 | DBMET03026 | |
| 0.079 | 0.242 | 0.133 | Nitric oxide antagonist | 0.133 0.114 DBMET03021 | DBMET03021 | |
| 0.152 | 0.319 | 0.351 | MAP kinase kinase 3 inhibitor | 0.351 0.004 DBMET03027 | DBMET03027 | |
| 0.052 | 0.225 | 0.123 | Thioredoxin reductase inhibitor | 0.118 0.018 DBMET03019 0.123 0.016 DBMET03020 | DBMET03020 | |
| 0.161 | 0.336 | 0.283 | Apoptosis agonist | 0.283 0.184 DBMET03021 0.236 0.229 DBMET03026 | DBMET03021 | |
| 0.05 | 0.234 | 0.104 | Phosphodiesterase inhibitor | 0.104 0.101 DBMET03019 | DBMET03019 | |
| 0.073 | 0.265 | 0.127 | NOS3 expression enhancer | 0.124 0.107 DBMET03021 0.127 0.103 DBMET03026 | DBMET03026 | |
| 0.031 | 0.231 | 0.078 | HIV-1 integrase inhibitor | 0.07 0.048 DBMET03021 0.078 0.04 DBMET03026 | DBMET03026 | |
| 0.123 | 0.325 | 0.199 | Sodium/bile acid cotransporter inhibitor | 0.199 0.189 DBMET03021 | DBMET03021 | |
| 0.11 | 0.325 | 0.203 | Antithrombotic | 0.203 0.173 DBMET03027 | DBMET03027 | |
| 0.168 | 0.384 | 0.295 | Antiinflammatory | 0.285 0.229 DBMET03021 0.295 0.22 DBMET03026 | DBMET03026 | |
| 0.08 | 0.303 | 0.234 | Antioxidant | 0.234 0.093 DBMET03021 0.229 0.096 DBMET03026 | DBMET03021 | |
| 0.042 | 0.269 | 0.103 | Thioredoxin inhibitor | 0.098 0.05 DBMET03019 0.103 0.045 DBMET03020 | DBMET03020 | |
| 0.034 | 0.345 | 0.125 | Lipid peroxidase inhibitor | 0.116 0.098 DBMET03021 0.125 0.089 DBMET03026 | DBMET03026 | |
| 0.025 | 0.347 | 0.104 | Topoisomerase II inhibitor | 0.104 0.082 DBMET03026 | DBMET03026 | |
| 0.019 | 0.371 | 0.114 | M18 aspartyl aminopeptidase inhibitor | 0.114 0.076 DBMET03021 | DBMET03021 | |
| 0.074 | 0.462 | 0.252 | Nootropic | 0.252 0.106 DBMET03020 | DBMET03020 | |
| 0.043 | 0.441 | 0.404 | Vasodilator | 0.404 0.022 DBMET03020 | DBMET03020 | |
| 0.017 | 0.455 | 0.069 | Factor IXa inhibitor | 0.069 0.021 DBMET03027 | DBMET03027 | |
| 0.004 | 0.542 | 0.035 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.035 0.024 DBMET03027 | DBMET03027 | |
| 0.005 | 0.742 | 0.046 | Dopamine transporter inhibitor | 0.046 0.036 DBMET03027 | DBMET03027 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |